Literature DB >> 12507954

The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration.

Patrick M Bossuyt1, Johannes B Reitsma, David E Bruns, Constantine A Gatsonis, Paul P Glasziou, Les M Irwig, David Moher, Drummond Rennie, Henrica C W de Vet, Jeroen G Lijmer.   

Abstract

The quality of reporting of studies of diagnostic accuracy is less than optimal. Complete and accurate reporting is necessary to enable readers to assess the potential for bias in the study and to evaluate the generalisability of the results. A group of scientists and editors has developed the STARD (Standards for Reporting of Diagnostic Accuracy) statement to improve the reporting the quality of reporting of studies of diagnostic accuracy. The statement consists of a checklist of 25 items and flow diagram that authors can use to ensure that all relevant information is present. This explanatory document aims to facilitate the use, understanding and dissemination of the checklist. The document contains a clarification of the meaning, rationale and optimal use of each item on the checklist, as well as a short summary of the available evidence on bias and applicability. The STARD statement, checklist, flowchart and this explanation and elaboration document should be useful resources to improve reporting of diagnostic accuracy studies. Complete and informative reporting can only lead to better decisions in healthcare.

Mesh:

Year:  2003        PMID: 12507954     DOI: 10.1373/49.1.7

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  215 in total

1.  Mindray 3-directional NMT Module (a new generation "Tri-axial" neuromuscular monitor) versus the Relaxometer mechanomyograph and versus the TOF-Watch SX acceleromyograph.

Authors:  Ashraf A Dahaba; Ismet Suljevic; Zhao Yang Xiao; Kun Wang
Journal:  J Clin Monit Comput       Date:  2018-12-05       Impact factor: 2.502

2.  Diagnosis: highlighting the gaps.

Authors:  Sharon E Straus
Journal:  J Gen Intern Med       Date:  2003-03       Impact factor: 5.128

3.  Assessing the diagnostic accuracy of immunodiagnostic techniques in the diagnosis of schistosomiasis japonica: a meta-analysis.

Authors:  HuiPing Zhu; ChuanHua Yu; Xin Xia; GuoYing Dong; Jie Tang; Long Fang; Yukai Du
Journal:  Parasitol Res       Date:  2010-07-06       Impact factor: 2.289

4.  Immunoenzymatic assay for the diagnosis of American tegumentary leishmaniasis using soluble and membrane-enriched fractions from infectious Leishmania (Viannia) braziliensis.

Authors:  Jamyra Iglesias Cataldo; Fernanda Carvalho de Queiroz Mello; Eliame Mouta-Confort; Maria de Fátima Madeira; Armando de Oliveira Schubach; Marcelo da Silva Genestra; Flávia Coelho Ribeiro; Célia de Fátima Moreira-Venâncio; Sônia Regina Lambert Passos
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

5.  A Randomised Assessment of Trainee Doctors' Understanding and Interpretation of Diagnostic Test Results.

Authors:  V L Parker; J E Ritchie; T M Drake; J Hookham; S P Balasubramanian
Journal:  World J Surg       Date:  2016-01       Impact factor: 3.352

Review 6.  Assessing the quality of studies on the diagnostic accuracy of tumor markers.

Authors:  Peter J Goebell; Ashish M Kamat; Richard J Sylvester; Peter Black; Michael Droller; Guilherme Godoy; M'Liss A Hudson; Kerstin Junker; Wassim Kassouf; Margaret A Knowles; Wolfgang A Schulz; Roland Seiler; Bernd J Schmitz-Dräger
Journal:  Urol Oncol       Date:  2014-08-20       Impact factor: 3.498

7.  D-dimer threshold increase with pretest probability unlikely for pulmonary embolism to decrease unnecessary computerized tomographic pulmonary angiography.

Authors:  J A Kline; M M Hogg; D M Courtney; C D Miller; A E Jones; H A Smithline
Journal:  J Thromb Haemost       Date:  2012-04       Impact factor: 5.824

8.  Clinical chemistry through Clinical Chemistry: a journal timeline.

Authors:  Robert Rej
Journal:  Clin Chem       Date:  2004-12       Impact factor: 8.327

9.  Clinical diagnosis of lacunar stroke in the first 6 hours after symptom onset: analysis of data from the glycine antagonist in neuroprotection (GAIN) Americas trial.

Authors:  Stephen J Phillips; Dingwei Dai; Arnold Mitnitski; Gordon J Gubitz; Karen C Johnston; Walter J Koroshetz; Karen L Furie; Sandra Black; Darell E Heiselman
Journal:  Stroke       Date:  2007-08-23       Impact factor: 7.914

Review 10.  The validity of the multi-informant approach to assessing child and adolescent mental health.

Authors:  Andres De Los Reyes; Tara M Augenstein; Mo Wang; Sarah A Thomas; Deborah A G Drabick; Darcy E Burgers; Jill Rabinowitz
Journal:  Psychol Bull       Date:  2015-04-27       Impact factor: 17.737

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.